Status:

TERMINATED

A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema

Lead Sponsor:

Aviceda Therapeutics, Inc.

Conditions:

Diabetic Macular Edema

Diabetic Retinopathy

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

A Phase 2 study to determine the safety and preliminary efficacy of intravitreal injections of AVD-104, a novel glyco-mimetic nanoparticle, in reducing macular edema associated with diabetic retinopat...

Detailed Description

The primary objective is to evaluate the tolerability and treatment effect of intravitreal injections (IVT) of AVD-104 in participants with diabetic macular edema (DME). Participants will receive eith...

Eligibility Criteria

Inclusion

  • Diagnosis of diabetes mellitus (type 1 or 2), as defined by the World Health Organization and/or American Diabetes Association
  • Decreased visual acuity (VA) due to DME, with Best corrected visual acuity (BCVA) letter score of 75-20 letters on ETDRS-like charts (20/32-20/320 Snellen equivalent)
  • DME represented by macular thickening on Spectral domain optical coherence tomography (SD-OCT) involving the center of the macula: Central subfield thickness (CST) ≥325 μm

Exclusion

  • Any IVT anti-vascular endothelial growth factor (VEGF) treatment within 3 months before randomization
  • Any history of pan-retinal photocoagulation (PRP) treatment
  • Any use of Iluvien® (Alimera Sciences, Inc., Alpharetta, GA) in the last 3 years; or Ozurdex® (Abbvie, Chicago, IL) or Xipere (Bausch \& Lomb, Vaughan, Ontario, Canada) in the last 6 months
  • History of macular laser photocoagulation
  • Any signs of high-risk proliferative diabetic retinopathy (PDR)

Key Trial Info

Start Date :

November 30 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 5 2024

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT06181227

Start Date

November 30 2023

End Date

April 5 2024

Last Update

July 14 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Erie Retina Research

Erie, Pennsylvania, United States, 16507

2

Texas Retina Associates

Dallas, Texas, United States, 75231

3

West Texas Retina Consultants

Wichita Falls, Texas, United States, 76309